The recurrence of Helicobacter pylori infection: incidence and variables influencing it. A critical review. (Q36243478)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16128956%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

review article

1 reference

title

The recurrence of Helicobacter pylori infection: incidence and variables influencing it. A critical review (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16128956%20AND%20SRC:MED&resulttype=core&format=json

Helicobacter pylori infectious disease

6 January 2020

main subject

Helicobacter pylori

0 references

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16128956%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Javier P Gisbert

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 September 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16128956%20AND%20SRC:MED&resulttype=core&format=json

The American Journal of Gastroenterology

6 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16128956%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

volume

100

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16128956%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16128956%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

page(s)

2083-2099

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16128956%20AND%20SRC:MED&resulttype=core&format=json

Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review

6 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.50043.X

Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.50043.X

Recurrence of Helicobacter pylori infection after successful eradication: nature and possible causes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.50043.X

Reinfection versus recrudescence in Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.50043.X

Reinfection rate following effective therapy against Helicobacter pylori infection in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.50043.X

Triple therapy for Helicobacter pylori eradication: a comparison of pantoprazole once versus twice daily.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.50043.X

Eradication of Helicobacter pylori compared with long-term acid suppression in duodenal ulcer disease. A randomized trial with 2-year follow-up. The Danish Ulcer Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.50043.X

Eradication of Helicobacter pylori infection in patients with duodenal ulcer and non-ulcer dyspepsia and analysis of one-year reinfection rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.50043.X

Total family unit Helicobacter pylori eradication and pediatric re-infection rates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.50043.X

Reinfection rate in children after successful Helicobacter pylori eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.50043.X

Duodenal ulcer treated with Helicobacter pylori eradication: seven-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.50043.X

After the eradication of Helicobacter pylori infection, relapse is a serious problem in Turkey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.50043.X

Recrudescence and reinfection with Helicobacter pylori after eradication therapy in Bangladeshi adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.50043.X

Helicobacter pylori reinfection rates in children after eradication therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.50043.X

Long-term follow-up study of serum immunoglobulin G and immunoglobulin A antibodies after Helicobacter pylori eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.50043.X

Effect of eradication of Helicobacter pylori on the benign gastric ulcer recurrence--a 24 month follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.50043.X

Prevalence of H. pylori-infection in family members of H. pylori positive and its influence on the reinfection rate after successful eradication therapy: a two-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.50043.X

Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.50043.X

High rates of recurrence and of transient reinfections of Helicobacter pylori in a population with high prevalence of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.50043.X

One week eradication regimen for Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.50043.X

Omeprazole triple therapy versus omeprazole quadruple therapy for healing duodenal ulcer and eradication of Helicobacter pylori infection: a 24-month follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.50043.X

PROSPECTIVE DOUBLE-BLIND TRIAL OF DUODENAL ULCER RELAPSE AFTER ERADICATION OF CAMPYLOBACTER PYLORI

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.50043.X

Duodenal ulcer relapse is not always associated with recurrence of H. pylori infection: a prospective three-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.50043.X

Amoxycillin plus tinidazole for Campylobacter pylori gastritis in children: assessment by serum IgG antibody, pepsinogen I, and gastrin levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.50043.X

Is the recurrence of Helicobacter pylori infection after eradication therapy resultant from recrudescence or reinfection, in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.50043.X

Long-term recurrence rate after treatment of Helicobacter pylori infection in children and adolescents in Estonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.50043.X

The effect of the eradication of Helicobacter pylori infection on hemorrhage because of duodenal ulcer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.50043.X

Cure of duodenal ulcer associated with eradication of Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.50043.X

Recurrence of Helicobacter pylori infection and the long-term outcome of peptic ulcer after successful eradication in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.50043.X

Helicobacter pylori reinfection is common in Peruvian adults after antibiotic eradication therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.50043.X

Triple therapy with sucralfate, amoxycillin and metronidazole for healing duodenal ulcer and eradicating Helicobacter pylori infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.50043.X

Six-year follow-up after successful triple therapy for Helicobacter pylori infection in patients with peptic ulcer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.50043.X

One year follow-up of patients after successful helicobacter pylori eradication therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.50043.X

Reduced relapse rate in duodenal ulcer disease leads to normalization of psychological distress: twelve-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.50043.X

What is the Helicobacter pylori global reinfection rate?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.50043.X

Prevalence of Helicobacter pylori infection in coronary artery disease and effect of its eradication on coronary lumen reduction after percutaneous coronary angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.50043.X

Differentiation between reinfection and recrudescence of helicobacter pylori strains using PCR-based restriction fragment length polymorphism analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.50043.X

Evidence of gastritis with several Helicobacter pylori strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.50043.X

Evaluation of new anti-infective drugs for the treatment of gastritis and peptic ulcer disease associated with infection by Helicobacter pylori. Infectious Diseases Society of America and the Food and Drug Administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.50043.X

Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.50043.X

Role of partner's infection in reinfection after Helicobacter pylori eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.50043.X

A novel tablet-based 13C urea breath test for Helicobacter pylori with enhanced performance during acid suppression therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.50043.X

Review article: 13C-urea breath test in the diagnosis of Helicobacter pylori infection -- a critical review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.50043.X

Epidemiology of Helicobacter pylori Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.50043.X

Active infection with Helicobacter pylori in healthy couples

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.50043.X

Helicobacter pylori in children with peptic ulcer and their families

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.50043.X

Relation between infection with Helicobacter pylori and living conditions in childhood: evidence for person to person transmission in early life

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.50043.X

Childhood living conditions and Helicobacter pylori seropositivity in adult life

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.50043.X

The relationship between gastric-oral Helicobacter pylori and oral hygiene in patients with vitamin B12-deficiency anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.50043.X

Oral cavity as a potential source of gastric reinfection by Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.50043.X

Meta-analysis: Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy for the prevention of recurrent bleeding from peptic ulcer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.50043.X

Long term follow up of Helicobacter pylori induced gastric diffuse large B cell MALT lymphoma following eradication treatment alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.50043.X

Recurrence ofHelicobacter pyloriinfection in adults with intellectual disability

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.50043.X

Clinical and Histologic Predictors of Helicobacter pylori Infection Recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.50043.X

10.1111/J.1572-0241.2005.50043.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16128956%20AND%20SRC:MED&resulttype=core&format=json

release_qj5l7c63r5antmohq3c77l64ge

6 January 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/qj5l7c63r5antmohq3c77l64ge

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16128956%20AND%20SRC:MED&resulttype=core&format=json